Development of antisense oligonucleotide drugs to supress expression of the DUX4 protein as a therapy for Fascioscapulohumeral Muscular Dystrophy - Research - Royal Holloway, University of London

Home > Biological Sciences home > Research > Profile > Projects > Development of antisense oligonucleotide drugs to supress expression of the DUX4 protein as a therapy for Fascioscapulohumeral Muscular Dystrophy

Development of antisense oligonucleotide drugs to supress expression of the DUX4 protein as a therapy for Fascioscapulohumeral Muscular Dystrophy

Project: Research

Status	Finished
Effective start/end date	1/08/14 → 31/07/18

Funding

Rosetrees Trust: £60,000, Rosetrees Trust: £17,000

Project relations

Development of cell-penetrating peptide-conjugated antisense oligonucleotides for the treatment of Fascioscapulohumeral Muscular Dystrophy
Project: Research

Activities

FSHD International Research Congress (USA)
Activity: Talk or presentation › Oral presentation

Research outputs

G-quadruplex ligands mediate downregulation of DUX4 expression
Research output: Contribution to journal › Article › peer-review

ID: 37636592

Biological Sciences home

Research

Profile

Royal Holloway, University of London
Egham,
Surrey,
TW20 0EX

T: +44 (0)1784 434455 T: +44 (0)1784 434455